Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on September 1, 2026

Sep. 1, 2026

Descartes Acquires Extensiv

Indeterminate GlobeNewswire

Sep. 1, 2026

Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Indeterminate GlobeNewswire

Sep. 1, 2026

Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY

Indeterminate GlobeNewswire

Sep. 1, 2026

Immunocore to present at upcoming investor conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Sensory Education Launches Sensory Diversity: A New Neuro-Affirming Guide to Navigating Sensory Struggles

Indeterminate GlobeNewswire

Sep. 1, 2026

Aquestive Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Syndax Announces Participation in September Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Remix Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer

Indeterminate GlobeNewswire

Sep. 1, 2026

Yodeck Launches AI Agent for Digital Signage Management

Indeterminate GlobeNewswire

Sep. 1, 2026

REPORT: AAFA Names 2026 Asthma Capitals, Highlights Risk Factors That Increase Asthma-Related ER Visits and Deaths

Indeterminate GlobeNewswire

Sep. 1, 2026

Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Jade Biosciences to Participate in Upcoming Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

ElevateBio Appoints Steven Falcone as Chief Operating Officer

Indeterminate GlobeNewswire

Sep. 1, 2026

ROC Completes Acquisition of ZTC; Strengthening Competitive Position for ROC’s Vision AI Platform

Indeterminate GlobeNewswire

Sep. 1, 2026

BioCryst to Present at Upcoming Investor Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Award-Winning BrewDog Unleashes Liquid Visions, a Bold New Craft Beer Series Built to Light Up Retail Shelves

Indeterminate GlobeNewswire